Ranzani OT, Bozza FA(2022).
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response.
Clin Microbiol Infect. 28(8):1166-1167. 10.1016/j.cmi.2022.03.037.
Halpern B, Ranzani OT(2022).
Lessons From the COVID-19 Pandemic in Latin America: Vulnerability Leading to More Vulnerability.
Am J Public Health. 112(S6):S579-S580. 10.2105/ajph.2022.306812.
Hitchings MDT, Ranzani OT, Torres MSS, Ko AI, Croda J(2021).
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study.
Lancet Reg Health Am. 1:100025. 10.1016/j.lana.2021.100025.
Ranzani OT, Hitchings MDT, Dorion M, Ko AI, Croda J(2021).
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
BMJ. 374:n2015. 10.1136/bmj.n2015.
Einav S, Ranzani OT(2020).
Focus on better care and ethics: Are medical ethics lagging behind the development of new medical technologies?.
Intensive Care Med. 46(8):1611-1613. 10.1007/s00134-020-06112-4.
Ranzani OT, Milà C, Sanchez M, Kinra S, Tonne C(2020).
Association between ambient and household air pollution with carotid intima-media thickness in peri-urban South India: CHAI-Project.
Int J Epidemiol. 49(1):69-79. 10.1093/ije/dyz208.
Tonne C, Ranzani OT(2018).
Is occupational biomass smoke exposure an overlooked driver of respiratory health?.
Occup Environ Med. 75(10):687-688. 10.1136/oemed-2017-104691.
Ranzani OT, Li Bassi G, Torres A(2016).
Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis.
Intensive Care Med. 42(12):2119-2120. 10.1007/s00134-016-4469-2.
Noritomi DT, Zigaib R, Ranzani OT, Teich V(2016).
Evaluation of cost-effectiveness from the funding body's point of view of ultrasound-guided central venous catheter insertion compared with the conventional technique.
Rev Bras Ter Intensiva. 28(1):62-9. 10.5935/0103-507x.20160014.
Ranzani OT, Zampieri FG, Park M(2013).
Highlighting the important effect of systemic lupus erythematosus on platelet count of critically ill patients.
Intensive Care Med. 39(10):1882-3. 10.1007/s00134-013-3019-4.
Ranzani OT, Prada LF, Zampieri FG, Azevedo LC, Park M(2012).
Failure to reduce C-reactive protein levels more than 25% in the last 24 hours before intensive care unit discharge predicts higher in-hospital mortality: a cohort study.
J Crit Care. 27(5):525.e9-15. 10.1016/j.jcrc.2011.10.013.